Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency clinical trials

Explore recruiting pulmonary emphysema due to alpha 1 antitrypsin deficiency clinical trials.

Recruiting pulmonary emphysema due to alpha 1 antitrypsin deficiency studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alphal-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency

Sweden, France, Finland, Estonia, Denmark, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin Deficiency

Finland, Sweden, Poland, France, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency trials by city

Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Toronto Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Vancouver Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Montreal Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Calgary Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Edmonton Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Ottawa Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Winnipeg Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Quebec City Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Hamilton Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Kitchener Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in London Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Halifax Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in New York Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Los Angeles Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Chicago Pulmonary Emphysema Due To Alpha 1 Antitrypsin Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease